Insulin-like growth factor I (IGF-I)/insulin induced cytosolic p42/p44 mitogen-activated protein kinase (MAPK) activation in a time
INTRODUCTION
Mitogen-activated protein kinases (MAPKs) or extracellular signal-regulated kinases (ERKs) are a family of serine/threonine kinases activated by receptor tyrosine-kinases such as the insulin-like growth factor I (IGF-I) and insulin receptors, cytokine receptors, and seven spanning heterotrimeric G proteins (1, 2) . Two members of this family, p42 and p44 MAPKs, have been widely studied, and a role for these kinases in the proliferation (3) (4) (5) or in the differentiation signal transduction pathways (4, 6) has been proposed. These MAPKs are activated by tyrosine and threonine phosphorylation (7) (8) . Upon activation, they can be translocated to the nucleus (9, 10) where they can phosphorylate transcription factors (10, 11) .
IGF-I and insulin as well as other growth factors activate MAPKs in different cell types (12) (13) (14) (15) (16) through MAPK kinase (MEK) activation (17) (18) , but the possible role for MAPKs in the regulation of proliferation/ differentiation balance is poorly understood. A role for MAPKs in the regulation of fibroblast cell growth (3) (4) (5) has been demonstrated. However, its role in the differentiation processes is not so well defined, and although it has been proposed that MAPKs play a role in the neuronal differentiation of PC12 cells (4, 6, 19) and in the insulin-induced 3T3 L1 adipocyte differentiation (20) , other data indicate that sustained MAPK activation is not sufficient to determine neuronal differentiation (21) and that MAPK cascade has a negative role in the insulin-induced 3T3 L1 adipocyte differentiation (22) .
Brown adipose tissue is specialized in heat production by the mechanism called "non-shivering" thermo-genesis (23) that is carried out by the uncoupling protein (UCP-1). In particular, rat fetal brown adipocytes already express UCP-1, and this expression continues after birth (24) . Different signals that induce the UCP-1 expression, such as noradrenaline (25) and T 3 (26) (27) , seem to be involved in the thermogenic differentiation. Insulin induces the lipogenic differentiation in rat fetal brown adipocytes (28) , while IGF-I is a potent mitogen that also plays an important role in rat fetal brown adipocytic differentiation (29, 30) , particularly in the thermogenic differentiation (31) . However, the mechanisms mediating the IGF-I and insulin effects are still poorly understood, although it is known that Ras proteins play a crucial role in some IGF-I/insulin-signaling pathways (13, 32, 33) . In particular, Ras proteins mediate the insulin/IGF-I induced adipocytic differentiation of 3T3 L1 cells (13, 32) and the IGF-induced UCP-1 expression in rat fetal brown adipocytes (34, 35) . Moreover, since Ras proteins mediate the IGF-I/ insulin induced MAPK activation in different cell types (13) (14) (15) (16) 36) , this IGF-I/insulin-Ras-MAPK cascade might have an important role in the regulation of proliferation and/or differentiation in rat fetal brown adipocytes. Therefore, we have characterized the IGF-I/ insulin-induced MAPK pathway and tried to establish its role on the balance between proliferation and differentiation processes in rat fetal brown adipocytes. We present evidence demonstrating that IGF-I and insulin activate p42/p44 MAPKs through a MEKdependent pathway and this IGF-I/insulin-induced MAPK activation is a requirement for proliferation, but inhibits differentiation in brown adipocytes.
RESULTS

Cytosolic p42/p44 MAPKs Are Activated by IGF-I and Insulin in Rat Fetal Brown Adipocytes
IGF-I and insulin are known to activate MAPKs in different cell types with a maximum activation after approximately 5 min of treatment (12, 13) ; therefore, we wished to determine whether this was also true for rat fetal brown adipocytes.
Cytosolic MAPK activity, determined by quantification of active p44/p42 MAPKs detected by Western blot analysis using an antiphospho-p44/p42 MAPKs antibody, was increased after treatment of the cells with different concentrations of IGF-I or insulin for 5 min (Fig. 1) . Maximum value was reached with 20 nM to 1 M insulin or 2.5-10 nM IGF-I.
Even though we measured MAPK activity after 5 min of treatment with IGF-I or insulin, which is considered the point of maximum activation, a complete time course study of the MAPK activity was carried out in rat fetal brown adipocytes. MAPK stimulation by IGF-I and insulin showed a fast kinetic of activation with a peak of activation at about 5 min of treatment (Fig. 2) , returning to essential baseline values after 25 min to 2 h of treatment either with IGF-I or insulin.
Nuclear p42/p44 MAPKs Are Activated by IGF-I and Insulin Treatment in Rat Fetal Brown Adipocytes
We also analyzed whether IGF-I or insulin could induce changes in the nuclear p42/p44 MAPK activity. A time course of MAPK activity was carried out in nuclear extracts from cells treated with IGF-I or insulin (Fig. 3) . MAPK activity detected in the nuclear fraction of untreated cells (control) was around 30-40% that of the cytosolic fraction. Treatment of the cells with IGF-I or insulin rapidly increased the levels of active MAPKs with a peak around 5 min, decreasing to baseline levels after 15-25 min of treatment in both cases (Fig.  3) , although a certain amount of phospho-MAPKs were detected after 3-5 h.
MEK1 Mediates the IGF-I and Insulin-Induced Activation of Cytosolic and Nuclear p42/p44-MAPKs in Rat Fetal Brown Adipocytes
Since it has been described that MEK mediates the p42 /44 mapk activation induced by several signals in different cell types (2), we tried to determine whether MEK was also upstream of MAPK in the IGF-I/insulininduced MAPK cascade in rat fetal brown adipocytes. To accomplish that, serum-starved cells untreated or pretreated with the MEK1 inhibitor, PD98059 (20 M), were triggered with IGF-I or insulin for 5 min, and phospho-MAPK levels were measured by Western blot in cytosol and nucleus.
As is shown in Fig. 4A , IGF-I and insulin increased cytosolic MAPK activity in the cells maintained in the absence of the MEK1 inhibitor, while no effect was observed in cells pretreated with this compound. Similarly, MEK1 inhibition blocked insulin/IGF-I-induced p42/p44-MAPKs activation in the nucleus (Fig. 4B) .
Based on these results, MEK1 appears to be the essential upstream element for p42/p44-MAPK activation in cytosol and nucleus in the IGF-I/insulin-MAPK cascade in rat fetal brown adipocytes.
MAPK Cascade Is Responsible for IGF-I and Insulin-Induced Proliferation in Rat Fetal Brown Adipocytes
IGF-I and insulin are involved in the regulation of proliferation and differentiation in rat fetal brown adipocytes (29) . Since an increase in nuclear p42/44 mapk activity was induced by IGF-I and insulin, we tried to establish whether it might have a role in the regulation of the cell cycle. To do that, the effect of the MEK1 inhibitor, PD 98059, on the IGF-I/insulin-induced proliferation was assessed at 24 h, since this is the opti- Results from flow cytometric analysis of the cell cycle under different conditions are represented in Table 1 . Cells treated with IGF-I for 24 h presented a statistically significant increase (**, P Ͻ 0.01) in the percentage of cells in the SϩG2/M phases of the cell cycle. Similar results were obtained for insulin (*, P Ͻ 0.05). However, the IGF-I/insulin effect on mitogenesis was blunted by MEK inhibition.
Data obtained from quantification of PCNA amounts detected by Western blot analysis (Fig. 5A ) corroborated those from flow cytometric cell cycle analysis. PCNA levels were significatively increased by IGF-I and insulin after 24 h of treatment (**, P Ͻ 0.01). However, MEK 1 inhibition abolished this effect (**, P Ͻ 0.01).
Data from the [ 3 H]thymidine incorporation assay ( Fig. 5B ) confirmed those from cell cycle analysis and PCNA quantification. IGF-I and insulin significantly increased [ 3 H]thymidine incorporation (**, P Ͻ 0.01) when compared with control value. However, this increase in DNA synthesis induced by IGF-I/insulin was completely prevented by the presence of the MEK1 inhibitor (**, P Ͻ 0.01). Control value was also decreased by pretreatment with this inhibitor. These results demonstrate that p42/p44 MAPKs are required for the IGF-I/insulin-induced proliferation in rat fetal brown adipocytes.
MAPK Cascade Plays a Negative Role in Adipocytic and Thermogenic Differentiation in Rat Fetal Brown Adipocytes
IGF-I/insulin induces differentiation-related gene expression in rat fetal brown adipocytes (28), IGF-I being specially involved in the thermogenic differentiation of these cells (31) . Since IGF-I and insulin activated p44/42MAPKs in these cells, we wished to determine the function of these kinases in the differentiation processes. To assess the role of MAPKs on the thermogenic and adipocytic differentiation, we studied the effect of the MEK1 inhibitor PD98059 on the IGF-I-induced UCP-1 mRNA expression and on the insulin-induced fatty acid synthase (FAS) mRNA expression after short-(24 h) and long-term treatments (4 days).
As is shown in Fig. 6 , the presence of the MEK1 inhibitor potentiated the IGF-I effect, increasing the UCP-1 mRNA expression at 24 h (Fig. 6A ) and 4 days (Fig. 6B ) (**, P Ͻ 0.01). Moreover, MEK1 inhibition in control cells induced a similar increase in the UCP-1 mRNA levels as the one induced by IGF-I at 24 h and 4 days (*, P Ͻ 0.05). Similarly, pretreatment of the cells with the MEK1 inhibitor potentiated the insulin effect, increasing the FAS mRNA expression at 24 h (**, P Ͻ 0.01) and 4 days (*, P Ͻ 0.05). However, no significant effect of this inhibitor was detected on control FAS mRNA expression. These results suggest that the IGF-I/insulin-induced MAPK activation mediated by MEK attenuates the signaling involved in differentiation in brown adipocytes. To confirm that MAPK cascade activation plays a negative role in the IGF-I/insulin-induced differentiation in brown adipocytes, transient transfections of an active MEK mutant construct (R4F) were carried out, and UCP-1 and FAS mRNAs were measured. As a control, transient transfections with the empty vector were also carried out. To do that, a brown adipocyte cell line (MB 4.8.2) previously generated (37) by transfection with a SV40 LTag construct and a wild-type ras construct was used, since transfection efficiencies in primary brown adipocytes were lower than 1% and no effects of transfected R4F could be detected.
As is shown in Fig. 7A , untransfected control MB 4.8.2 cells presented certain levels of active p42/p44-MAPKs (5-to 6-fold higher than those from primary cells). These levels were slightly increased after treatment with IGF-I and insulin for 24 h. Similar results were obtained in cells transfected with the empty vector. When cells were transiently transfected with the active MEK mutant (R4F) construct, the levels of active p42/p44-MAPKs were significantly (***, P Ͻ 0.001) increased (8-to 10-fold). This increase in MAPK activity in transfected cells did not modify the low levels of UCP-1 and FAS mRNAs expressed in control cells (Fig. 7B) . However, the IGF-I and insulin effects inducing UCP-1 or FAS mRNA were reduced by 50% when compared with untransfected cells, respectively (**, P Ͻ 0.01). Transfection with the empty vector did not affect IGF-I-induced UCP-1 or insulininduced FAS mRNAs. Therefore, these results indicate that MAPK cascade plays a negative role in the regulation of the IGF-I/insulin-induced differentiation in brown adipocytes.
It should be also noted that, in the brown adipocyte cell line, MB 4.8.2, 4-fold more total RNA was necessary for detection of FAS and UCP-1 mRNAs by Northern blot analysis as compared with primary cells. This fact might be a consequence of the high basal p42/ p44 MAPK activity found in these cells, which would inhibit expression of the mRNAs' differentiation markers under control conditions.
DISCUSSION
It is well established that MAPK activation induces fibroblast cell growth (3) (4) (5) . However, its role in the differentiation process is not so well defined and some controversial data have been published. For that reason, we wanted to figure out the role played by p42/ 44MAPKs in the balance between proliferation and differentiation induced by IGF-I/insulin in fetal brown adipocytes.
IGF-I and insulin induced cytosolic MAPK activation in brown adipocytes as was previously described for other cell types (12, 13) . The analysis of nuclear MAPK activity in our system indicated that untreated cells present a basal activity that represents around 30-40% from that found in the cytosol. This nuclear MAPK activity was quickly increased by insulin and IGF-I. These results are very similar to those previously obtained in Hela cells triggered with serum (9) .
The upstream MAPK element in the MAPK cascade is MEK (MEK1 or MEK2) for many signals in different cell types (17, 18) . Our results also demonstrate that this is the case for rat fetal brown adipocytes, since the IGF-I/insulin-induced MAPK activation in cytosol and nucleus was completely prevented by the MEK1 inhibitor, PD 98059. In particular, based on the inhibitor dose needed to block the pathway, MEK1 is the mediator of MAPK activation. Therefore, MEK1 appears to be the essential upstream element in the IGF-I/ insulin-MAPK cascade in brown adipocytes.
Cell cycle analysis revealed that IGF-I and insulin induce the entry and progression through the cell cycle in a MAPK-dependent manner. Moreover, DNA synthesis and quantification of PCNA levels also indicate that MAPK activation is necessary for the IGF-I/ insulin-induced proliferation. The first peak of MAPK activation (5-40 min) might be associated with the G0/G1 transition and even progression through G1 phase, similar to what has been described for synchronized Swiss mouse 3T3 cells, where an increase in MAPK activity is produced in the G0/G1 boundary (38) . However, a role for MAPKs in other cell cycle phases cannot be excluded. In fact, it has been suggested that MAPKs would be important in cells progressing from M into G1 after release from a metaphase block (by 24-26 h) (38) . Other data also support that MAPKs can play different roles in the regulation of the different phases of the cell cycle (39) (40) .
The role for p44/p42MAPKs in the regulation of differentiation in different cell types is not well established. In PC12 cells, some data demonstrated that the sustained activation of the MAPK cascade induced neuronal differentiation (4, 6, 19) , while some others indicated that this sustained MAPK activation was not sufficient to determine neuronal differentiation in PC12 cells (41) or in H19-7 cells (21) . Regarding the adipocytic differentiation, some controversial data have also emerged concerning the possible role for MAPKs in the IGF-I/insulin-induced differentiation, particularly in 3T3 L1 cells. These cells are able to differentiate into adipocytes after exposure to physiological doses of IGF-I or pharmacological doses of insulin (42) . Ras proteins mediate this IGF-I/insulin-induced differentiation (13, 32) , glucose transport (43), and MAPK activation (13, 17, 36) . Therefore, the Ras/MAPK cascade or other Ras downstream pathways can be the mediators of the adipocytic differentiation. In fact, a study done using an antisense RNA against MAPK indicated that MAPK activation was necessary for the insulininduced 3T3 L1 adipocyte differentiation (20) . However, using other technical approaches, it has been demonstrated that p42/p44MAPKs play a negative role in the regulation of the IGF-I/insulin-induced differentiation of 3T3 L1 cells (22) . Moreover, another report (44) suggested that PI3K, another Ras downstream parallel pathway (45) , was involved in this process.
In fetal brown adipocytes, insulin plays an important role in the adipocytic differentiation (28) (29) (30) . IGF-I is also involved in the adipocytic and thermogenic differentiation of these cells (29, 31) , with a preferential role inducing the expression of the UCP-1 gene, which is the thermogenic differentiation marker (31) . Since Ras proteins are the mediators of the IGF-I-induced UCP-1 expression (34, 35) and Ras proteins mediate MAPK activation by IGF-I and insulin in different cell types, the rationale would be that MAPKs might be the downstream intermediates in the IGF-I/insulin differentiation signaling pathway. However, results presented here show that the MEK inhibition results in a potentiation of the IGF-I-induced UCP-1 mRNA expression and insulin-induced FAS mRNA expression. The inhibition of the MAPK cascade in control cells produced an increase in the expression of these adipocytic and thermogenic differentiation markers, although it was only statistically significant for UCP-1. Moreover, high levels of active MAPKs, obtained by means of transfection of an active MEK mutant (R4F) in a brown adipocyte cell line, decreased the IGF-Iinduced UCP-1 expression and the insulin-induced FAS expression. Additionally, the relatively high levels of active MAPKs present in this brown adipocyte cell line before transfection with R4F might explain the low endogenous expression of UCP-1 and FAS mRNAs. Therefore, these results indicate that the activation of the MAPK pathway results in attenuation of the adipocytic and thermogenic differentiation in brown adipocytes. These results are in agreement with data from Hu et al. (46) . These authors found that insulin, a potent mitogen for Rat-IR cells, induced the phosphorylation of the transcription factor, peroxisome proliferator-activated receptor ␥, which resulted in a reduction of its transcriptional activity and its ability to activate the adipocytic differentiation. The inhibition of MEK by PD98059 completely prevented peroxisome proliferator-activated receptor-␥ phosphorylation, leading those cells to adipocytic differentiation in response to insulin. Thus, these authors suggested that MAPKs might be very important to balance cell growth and differentiation. In our system, fetal brown adipocytes, which are able to proliferate and differentiate in primary culture, p42/44MAPK activation might also balance these two processes. Thus, depending on the extension of the activation of MAPKs and other signaling pathways, these cells could establish a balance between proliferation and differentiation. Upon IGF-I/ insulin binding to their receptors, an activation of MAPK cascade is produced that induces progression of the cells through the cell cycle, while the parallel PI3K activation is necessary for differentiation (47) . The balance between these pathways might determine whether the cells proliferate and/or differentiate. Thus, when the MAPK cascade is inhibited by the MEK1 inhibitor PD98059, brown adipocytes would be preferentially committed to perform differentiation in response to IGF-I/insulin. However, high levels of active p42/p44 MAPKs would preferentially induce proliferation blocking the signaling that leads to differentiation.
In conclusion, IGF-I and insulin induce mitogenesis in brown adipocytes in a MAPK-dependent manner. Inhibition of p42/p44 MAPKs is sufficient to arrest cells and potentiate adipocytic and thermogenic differenti-ation induced by IGF-I/insulin. Conversely, a high level of active p42/p44 MAPKs maintains cell proliferation but attenuates IGF-I/insulin-induced differentiation.
MATERIALS AND METHODS
Isolation of Fetal Brown Adipocytes and Culture
Fetal brown adipocytes from 20-day-old rat fetuses were isolated as described (24) and maintained in primary cultures. Cells were grown to 90% confluency in MEM supplemented with 10% FCS. Cells were starved overnight and triggered with IGF-I (1.4-10 nM) or insulin (1 nM to 1 M) when indicated, in the presence or in the absence of the MEK1 inhibitor PD98059 from New England Biolabs (Beverly, MA; 9900L) (6, 48) . In this case, cells were pretreated for 1 h with 20 M of PD98059 although a complete MEK inhibition was obtained by using a 10 M concentration after which the growth factors were added.
Culture of MB4.8.2 Brown Adipocyte Cell Line and Transfection Assays
MB 4.8.2 brown adipocyte cell line was grown in DMEM supplemented with 10% FCS. Cells were serum-starved overnight and maintained in the absence of serum when IGF-I and insulin effects on RNA expression or MAPK activity were studied.
Transient transfections were carried out using the MBS mammaliam transfection kit (catalog no. 35 200388) from Stratagene (La Jolla, CA) following the protocol supplied by the manufacturer. Cells were transfected with an active MEK mutant construct, pMCL-MKK1 (R4F), generously provided by Dr. N. Ahn (22) .
Transfection efficiencies ranged between 30-60% as determined by the ␤-galactosidase histochemical staining assay and by quantification of active p42/p44 MAPKs levels.
Preparation of Cytosolic and Nuclear Extracts
Cytosolic and nuclear extracts were prepared essentially as described previously (49) . Nuclear extracts were examined for cytosolic contamination by measuring the presence of malic enzyme by Western blot analysis. Less than 1% of malic enzyme was present in these extracts. p44/p42-MAPK Activities Assay: Phospho-MAPK Western Blot Analysis p44/p42-MAPK activities in cytosolic and nuclear extracts were determined by quantification of active MAPK levels by Western blot analysis using an anti-phospho-MAPK antibody from Promega (V6671; Madison, WI). Western blot analysis was carried out essentially as described (13, 16, 50) , using 10% SDS-polyacrylamide gels. Blots were developed using the enhanced chemiluminescence system (Amersham, Arlington Heights, IL).
Flow Cytometric Analysis
Analysis of the cell cycle was performed in a FACScan flow cytometer (Becton-Dickinson, San José , CA). The percentages of cells in Go/G1, S, or G2ϩM phases of the cell cycle were determined by staining cellular DNA with propidium iodide using the Bio-Rad (Richmond, CA) reagent kit (Kinesis 50, No. 470-0023), following the manufacturer's protocol.
Measurements were carried out using a Double Discriminator Module to discriminate doublets; 10,000 cells were acquired per sample.
PCNA Western Blot Analysis
PCNA Western blot analysis was carried out using a monoclonal anti-PCNA antibody from Boehringer Mannheim (Indianapolis, IN) following the same procedure described for MAPKs, but running the electrophoresis on 12% SDS-polyacrylamide gels.
[ 3 H]Thymidine Incorporation Assay
Cells were incubated with [ 3 H]thymidine (0.5 Ci/ml) for the last 4 h of stimulation with either IGF-I or insulin. Radioactivity present in trichloroacetic acid-insoluble material was quantitated in a ␤-counter.
RNA Extraction and Northern Blot Analysis
Total RNA was extracted with RNazol B (Biotecx Laboratories, Houston, TX) following the protocol supplied by the manufacturer. Northern blot analysis was carried out as previously described (25, 26) . For hybridization with different probes, the blots were stripped and rehybridized sequentially as needed in each case. Probes used included UCP-1 (51), FAS (52) , and 18S ribosomal to normalize. Autoradiograms were quantitated by using a computer-assisted densitometry from Molecular Dynamics (Sunnyvale, CA).
